|
|
|
Insider
Information: |
Shawver Laura |
Relationship: |
Director |
City: |
Cary |
State: |
NC |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
250,346 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$252,000 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
250,346 |
|
|
Total
Value |
$252,000 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Synthorx, Inc. |
THOR |
President and CEO, Dir... |
2020-01-23 |
0 |
2020-01-23 |
0 |
Premium* |
|
Relay Therapeutics, Inc. |
RLAY |
Director |
2023-05-24 |
40,000 |
|
0 |
Premium* |
|
Silverback Therapeutics, Inc. |
SBTX |
Director |
2023-09-01 |
210,346 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
40 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SBTX |
Silverback Therapeutics, ... |
Director |
|
2023-05-08 |
4 |
AS |
$6.16 |
$351,736 |
D/D |
(57,100) |
210,346 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
Director |
|
2023-07-06 |
4 |
AS |
$6.34 |
$212,554 |
D/D |
(33,510) |
210,346 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
Director |
|
2023-07-07 |
4 |
AS |
$6.36 |
$56,372 |
D/D |
(8,858) |
210,346 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
Director |
|
2023-07-05 |
4 |
AS |
$6.41 |
$199,552 |
D/D |
(31,112) |
210,346 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
Director |
|
2023-07-03 |
4 |
AS |
$6.73 |
$178,347 |
D/D |
(26,520) |
210,346 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
Director |
|
2023-06-01 |
4 |
AS |
$6.80 |
$496,801 |
D/D |
(73,059) |
210,346 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
Director |
|
2023-06-02 |
4 |
AS |
$6.95 |
$187,240 |
D/D |
(26,941) |
210,346 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
Director |
|
2023-08-03 |
4 |
AS |
$7.01 |
$183,018 |
D/D |
(26,107) |
210,346 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
Director |
|
2023-08-04 |
4 |
AS |
$7.06 |
$133,471 |
D/D |
(18,897) |
210,346 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
Director |
|
2023-08-02 |
4 |
AS |
$7.09 |
$257,265 |
D/D |
(36,281) |
210,346 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
Director |
|
2023-08-01 |
4 |
AS |
$7.19 |
$134,576 |
D/D |
(18,715) |
210,346 |
0 |
- |
|
SBTX |
Silverback Therapeutics, ... |
Director |
|
2023-09-01 |
4 |
AS |
$7.71 |
$770,520 |
D/D |
(100,000) |
210,346 |
0 |
- |
|
THOR |
Synthorx, Inc. |
President and CEO |
|
2020-01-23 |
4 |
D |
$68.00 |
$15,000,460 |
D/D |
(220,595) |
0 |
0 |
- |
|
THOR |
Synthorx, Inc. |
President and CEO |
|
2020-01-23 |
4 |
D |
$68.00 |
$1,700,000 |
I/I |
(25,000) |
0 |
0 |
- |
|
THOR |
Synthorx, Inc. |
President and CEO |
|
2019-12-30 |
4 |
D |
$70.63 |
$14,833,006 |
D/D |
(210,010) |
296,301 |
0 |
- |
|
40 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|